Premium
Letter: persistence of anti‐infliximab antibodies after discontinuation of infliximab in patients with IBD
Author(s) -
Steenholdt C.,
Brynskov J.,
Bendtzen K.
Publication year - 2012
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/j.1365-2036.2012.05204.x
Subject(s) - infliximab , discontinuation , medicine , ulcerative colitis , antibody , gastroenterology , thiopurine methyltransferase , inflammatory bowel disease , radioimmunoassay , immunology , tumor necrosis factor alpha , disease